
|Articles|August 5, 2016
Cost Containment Debate Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top news of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/cost-containment-debate-highlights-specialty-pharm" target="_blank">View the story "Cost Containment Debate Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Denosumab Biosimilars, Osvyrti and Jubereq, for Reference Products’ Indications
2
CDC’s Autism Statement Sparks New Concerns Over Vaccine Safety Messaging
3
Billions at Stake: 340B Program Integrity and Sustainability in 2024–2025
4
Patients With Long COVID Face Varying Trajectories, With Most Facing Symptoms Long After Infection
5












































































































































































































